Adiponectin (ADP) plays a protective role in diabetic nephropathy (DN) through the adiponectin receptor, mediates fatty acid metabolism, protects and compensates for further kidney damage, and prevents the development of clinical nephropathy [37]. Here, ADIPOQ is linked to kidney disorder.